Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 27102866)

Published in Sci Rep on April 22, 2016

Authors

Vilma Aho1, Hanna M Ollila1,2,3,4, Erkki Kronholm5, Isabel Bondia-Pons6,7, Pasi Soininen8,9, Antti J Kangas8, Mika Hilvo6, Ilkka Seppälä10, Johannes Kettunen2,8,9, Mervi Oikonen11, Emma Raitoharju10, Tuulia Hyötyläinen6,7, Mika Kähönen12, Jorma S A Viikari13, Mikko Härmä14, Mikael Sallinen14,15, Vesa M Olkkonen16,17, Harri Alenius18, Matti Jauhiainen2, Tiina Paunio2,3, Terho Lehtimäki10, Veikko Salomaa19, Matej Orešič6,7, Olli T Raitakari11,20, Mika Ala-Korpela8,9,21,22, Tarja Porkka-Heiskanen1

Author Affiliations

1: Department of Physiology, Faculty of Medicine, University of Helsinki, Finland.
2: Genomics and Biomarkers unit and Institute for Molecular Medicine FIMM, National Institute for Health and Welfare, Helsinki, Finland.
3: Department of Psychiatry, University of Helsinki and Helsinki University Hospital, Finland.
4: Stanford University Center for Sleep Sciences, Palo Alto, CA, USA.
5: Department of Chronic Disease Prevention, Population Studies Unit, National Institute for Health and Welfare, Turku, Finland.
6: VTT Technical Research Centre of Finland, Espoo, Finland.
7: Steno Diabetes Center A/S, Gentofte, Denmark.
8: Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland.
9: NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
10: Department of Clinical Chemistry, Fimlab Laboratories, and University of Tampere, School of Medicine, Tampere, Finland.
11: Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
12: Department of Clinical Physiology, University of Tampere and Tampere University Hospital, Tampere, Finland.
13: Department of Medicine, University of Turku, and Division of Medicine, Turku University Hospital, Turku, Finland.
14: Brain and Work Research Centre, Finnish Institute of Occupational Health, Helsinki, Finland.
15: Agora Center, University of Jyväskylä, Jyväskylä, Finland.
16: Minerva Foundation Institute for Medical Research, Helsinki, Finland.
17: Institute of Biomedicine, Anatomy, University of Helsinki, Finland.
18: Unit of Excellence for Immunotoxicology, Finnish Institute of Occupational Health, Helsinki, Finland.
19: Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
20: Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland.
21: Oulu University Hospital, Oulu, Finland.
22: Computational Medicine, School of Social and Community Medicine &Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.

Articles cited by this

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99

Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard. Psychiatry Clin Neurosci (2001) 36.50

Inflammation and metabolic disorders. Nature (2006) 33.33

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39

An empirical Bayes approach to inferring large-scale gene association networks. Bioinformatics (2004) 7.85

Circadian integration of metabolism and energetics. Science (2010) 6.86

Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol (1985) (2005) 6.47

Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med (2003) 6.21

Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol (2004) 6.08

MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics (2010) 5.77

Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care (2009) 5.13

Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res (2004) 4.67

Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol (2009) 4.09

Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet (2012) 4.08

Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest (2007) 3.89

Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation (2012) 3.38

Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell (2003) 2.99

Extensive and divergent effects of sleep and wakefulness on brain gene expression. Neuron (2004) 2.95

Metabolic consequences of sleep and sleep loss. Sleep Med (2008) 2.67

ATP-Binding cassette cholesterol transporters and cardiovascular disease. Circ Res (2006) 2.64

Cohort profile: the cardiovascular risk in Young Finns Study. Int J Epidemiol (2008) 2.51

Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain. Proc Natl Acad Sci U S A (2013) 2.50

High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst (2009) 2.49

Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol (2010) 2.17

Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling. Circulation (2013) 2.11

An epidemiological study of insomnia among the Japanese general population. Sleep (2000) 2.09

The human circadian metabolome. Proc Natl Acad Sci U S A (2012) 2.04

A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab (2010) 1.98

Problems associated with short sleep: bridging the gap between laboratory and epidemiological studies. Sleep Med Rev (2009) 1.97

Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci U S A (2013) 1.94

Sleep disturbance is associated with cardiovascular and metabolic disorders. J Sleep Res (2011) 1.82

Long-term leisure-time physical activity and serum metabolome. Circulation (2012) 1.81

The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci (2001) 1.80

Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes (2012) 1.80

Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLoS One (2009) 1.80

An immune response network associated with blood lipid levels. PLoS Genet (2010) 1.74

Cholesterol, inflammation and innate immunity. Nat Rev Immunol (2015) 1.72

High-density lipoprotein subfractions--what the clinicians need to know. Cardiology (2013) 1.71

Insomnia in central Pennsylvania. J Psychosom Res (2002) 1.71

Sleep loss and inflammation. Best Pract Res Clin Endocrinol Metab (2010) 1.69

Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res (2010) 1.69

Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev (2011) 1.65

Prevalence and treatment of insomnia in general practice. A longitudinal study. Eur Arch Psychiatry Clin Neurosci (1993) 1.61

Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Metabolism (2007) 1.60

Neurobehavioral dynamics following chronic sleep restriction: dose-response effects of one night for recovery. Sleep (2010) 1.51

Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem (1993) 1.43

An overview of reverse cholesterol transport. Eur Heart J (1998) 1.41

Network Analysis Tools: from biological networks to clusters and pathways. Nat Protoc (2008) 1.40

Sleep duration versus sleep insufficiency as predictors of cardiometabolic health outcomes. Sleep Med (2012) 1.40

Human blood metabolite timetable indicates internal body time. Proc Natl Acad Sci U S A (2012) 1.37

Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet (2015) 1.32

Self-reported sleep duration, all-cause mortality, cardiovascular mortality and morbidity in Finland. Sleep Med (2011) 1.30

Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues. Methods Mol Biol (2011) 1.28

Prolonged sleep restriction affects glucose metabolism in healthy young men. Int J Endocrinol (2010) 1.25

Effect of sleep deprivation on the human metabolome. Proc Natl Acad Sci U S A (2014) 1.22

HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Atherosclerosis (2009) 1.21

Molecular correlates of sleep and wakefulness in the brain of the white-crowned sparrow. J Neurochem (2007) 1.19

Human plasma lecithin-cholesterol acyltransferase. An elucidation of the catalytic mechanism. J Biol Chem (1986) 1.15

Impact of five nights of sleep restriction on glucose metabolism, leptin and testosterone in young adult men. PLoS One (2012) 1.14

Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol (2015) 1.11

ATP-binding cassette transporter G1 and high-density lipoprotein promote endothelial NO synthesis through a decrease in the interaction of caveolin-1 and endothelial NO synthase. Arterioscler Thromb Vasc Biol (2010) 1.10

Caveolae and intracellular trafficking of cholesterol. Adv Drug Deliv Rev (2001) 1.08

Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo. J Lipid Res (2008) 1.08

Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care (2002) 1.07

Crosstalk between reverse cholesterol transport and innate immunity. Trends Endocrinol Metab (2012) 1.04

Oxalic acid and diacylglycerol 36:3 are cross-species markers of sleep debt. Proc Natl Acad Sci U S A (2015) 1.03

Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans. Proc Natl Acad Sci U S A (2013) 1.02

Identification of human plasma metabolites exhibiting time-of-day variation using an untargeted liquid chromatography-mass spectrometry metabolomic approach. Chronobiol Int (2012) 1.00

Insomnia in the elderly: its prevalence and correlates in the general population. Med J Aust (1995) 1.00

Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem (1986) 0.99

Dietary determinants of serum paraoxonase activity in healthy humans. Atherosclerosis (2002) 0.98

Caveolin-1 does not affect SR-BI-mediated cholesterol efflux or selective uptake of cholesteryl ester in two cell lines. J Lipid Res (2003) 0.97

Hepatic ABCA1 and VLDL triglyceride production. Biochim Biophys Acta (2011) 0.95

MicroRNA control of high-density lipoprotein metabolism and function. Circ Res (2014) 0.93

Short sleep in young adults: Insomnia or sleep debt? Prevalence and clinical description of short sleep in a representative sample of 1004 young adults from France. Sleep Med (2011) 0.91

Inflammation, high-density lipoprotein and cardiovascular dysfunction. Curr Opin Infect Dis (2011) 0.91

Partial sleep restriction activates immune response-related gene expression pathways: experimental and epidemiological studies in humans. PLoS One (2013) 0.89

Metabolic nuclear receptor signaling and the inflammatory acute phase response. Trends Endocrinol Metab (2011) 0.86

HDL hypothesis: where do we stand now? Curr Atheroscler Rep (2014) 0.84

Temporal dissociation between myeloperoxidase (MPO)-modified LDL and MPO elevations during chronic sleep restriction and recovery in healthy young men. PLoS One (2011) 0.84

Sleep restriction for the duration of a work week impairs multitasking performance. J Sleep Res (2010) 0.84

Diurnal rhythms in the human urine metabolome during sleep and total sleep deprivation. Sci Rep (2015) 0.84

Blood microRNA profile associates with the levels of serum lipids and metabolites associated with glucose metabolism and insulin resistance and pinpoints pathways underlying metabolic syndrome: the cardiovascular risk in Young Finns Study. Mol Cell Endocrinol (2014) 0.84

Liver X receptors at the intersection of lipid metabolism and atherogenesis. Atherosclerosis (2015) 0.81

Functionality of HDL: antioxidation and detoxifying effects. Handb Exp Pharmacol (2015) 0.80

Short sleep duration, snoring and subjective sleep insufficiency are independent factors associated with both falling asleep and feeling sleepiness while driving. Intern Med (2012) 0.80

Mer signaling increases the abundance of the transcription factor LXR to promote the resolution of acute sterile inflammation. Sci Signal (2015) 0.78

The content of PPAR, LXR, and RXR and the PPAR DNA-binding activity in macrophages over the course of inflammation in mice. Bull Exp Biol Med (2009) 0.78

Caveolin-1 interacts with ATP binding cassette transporter G1 (ABCG1) and regulates ABCG1-mediated cholesterol efflux. Biochim Biophys Acta (2014) 0.78

Circadian rhythm, sleep pattern, and metabolic consequences: an overview on cardiovascular risk factors. Horm Mol Biol Clin Investig (2014) 0.77

No effects of short-term sleep restriction, in a controlled feeding setting, on lipid profiles in normal-weight adults. J Sleep Res (2013) 0.77

Self-reported obstructive sleep apnea, simple snoring, and various markers of sleep-disordered breathing as predictors of cardiovascular risk. Sleep Breath (2015) 0.76

Articles by these authors

Distribution and medical impact of loss-of-function variants in the Finnish founder population. PLoS Genet (2014) 2.89

A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet (2015) 2.84

Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet (2016) 1.90

Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. PLoS Med (2014) 1.60

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase. J Am Coll Cardiol (2016) 1.49

Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change. PLoS Med (2014) 1.42

Molecular mechanisms underlying variations in lung function: a systems genetics analysis. Lancet Respir Med (2015) 1.40

Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet (2015) 1.39

Chromosome X-wide association study identifies Loci for fasting insulin and height and evidence for incomplete dosage compensation. PLoS Genet (2014) 1.09

Genome-wide association analysis identifies six new loci associated with forced vital capacity. Nat Genet (2014) 1.07

High risk population isolate reveals low frequency variants predisposing to intracranial aneurysms. PLoS Genet (2014) 0.98

Cardiovascular risk factors in 2011 and secular trends since 2007: the Cardiovascular Risk in Young Finns Study. Scand J Public Health (2014) 0.96

Vigorous physical activity and carotid distensibility in young and mid-aged adults. Hypertens Res (2015) 0.90

Associations of multiple lipoprotein and apolipoprotein measures with worsening of glycemia and incident type 2 diabetes in 6607 non-diabetic Finnish men. Atherosclerosis (2015) 0.89

Lipoprotein subclass metabolism in nonalcoholic steatohepatitis. J Lipid Res (2014) 0.88

Cell Specific eQTL Analysis without Sorting Cells. PLoS Genet (2015) 0.87

Genome-wide associations for birth weight and correlations with adult disease. Nature (2016) 0.87

Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits. Diabetes (2014) 0.86

Age- and sex-specific causal effects of adiposity on cardiovascular risk factors. Diabetes (2015) 0.86

Gene × dietary pattern interactions in obesity: analysis of up to 68 317 adults of European ancestry. Hum Mol Genet (2015) 0.84

Genome-wide analysis identifies 12 loci influencing human reproductive behavior. Nat Genet (2016) 0.84

Childhood predictors of adult fatty liver. The Cardiovascular Risk in Young Finns Study. J Hepatol (2016) 0.81

Interrelationships between indices of longitudinal movement of the common carotid artery wall and the conventional measures of subclinical arteriosclerosis. Clin Physiol Funct Imaging (2015) 0.81

Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence. Int J Epidemiol (2016) 0.81

Metabolic profiling of fatty liver in young and middle-aged adults - cross-sectional and prospective analyses of the Young Finns Study. Hepatology (2016) 0.80

Effect of fatty and lean fish intake on lipoprotein subclasses in subjects with coronary heart disease: a controlled trial. J Clin Lipidol (2013) 0.80

Patients with type 1 diabetes show signs of vascular dysfunction in response to multiple high-fat meals. Nutr Metab (Lond) (2014) 0.80

Adult dyslipidemia prediction is improved by repeated measurements in childhood and young adulthood. The Cardiovascular Risk in Young Finns Study. Atherosclerosis (2015) 0.80

Lifetime measures of ideal cardiovascular health and their association with subclinical atherosclerosis: The Cardiovascular Risk in Young Finns Study. Int J Cardiol (2015) 0.79

Metabolic profiling of alcohol consumption in 9778 young adults. Int J Epidemiol (2016) 0.78

ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality. Heart (2014) 0.78

Metabolic signatures of birthweight in 18 288 adolescents and adults. Int J Epidemiol (2016) 0.77

Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets. Nat Genet (2017) 0.77

Childhood Socioeconomic Status in Predicting Metabolic Syndrome and Glucose Abnormalities in Adulthood: The Cardiovascular Risk in Young Finns Study. Diabetes Care (2016) 0.77

No Association of Coronary Artery Disease with X-Chromosomal Variants in Comprehensive International Meta-Analysis. Sci Rep (2016) 0.76

The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy. PLoS One (2015) 0.76

Exploring causality between TV viewing and weight change in young and middle-aged adults. The Cardiovascular Risk in Young Finns study. PLoS One (2014) 0.76

Integrative pathway genomics of lung function and airflow obstruction. Hum Mol Genet (2015) 0.76

Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence. BMC Med (2016) 0.76

Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure. J Am Heart Assoc (2017) 0.76

Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level. PLoS One (2017) 0.75

Incidence rates, correlates, and prognosis of electrocardiographic P-wave abnormalities - a nationwide population-based study. J Electrocardiol (2017) 0.75

Evidence for large-scale gene-by-smoking interaction effects on pulmonary function. Int J Epidemiol (2017) 0.75

The biomarker and causal roles of homoarginine in the development of cardiometabolic diseases: an observational and Mendelian randomization analysis. Sci Rep (2017) 0.75

Aortic sinus diameter in middle age is associated with body size in young adulthood. Heart (2017) 0.75

Longitudinal physical activity trajectories from childhood to adulthood and their determinants: The Young Finns Study. Scand J Med Sci Sports (2017) 0.75

Insomnia does not mediate or modify the association between MTNR1B risk variant rs10830963 and glucose levels. Diabetologia (2016) 0.75

Accumulation of Depressive Symptoms and Carotid Intima-Media Thickness: the Cardiovascular Risk in Young Finns Study. Ann Behav Med (2017) 0.75

Vitamin D and cognitive function: A Mendelian randomisation study. Sci Rep (2017) 0.75

Genome-wide association meta-analysis of fish and EPA+DHA consumption in 17 US and European cohorts. PLoS One (2017) 0.75